Pathway Category Top Level |
Pathway Category Second Level |
Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
09160 Human Diseases |
09161 Cancers |
hsa05212 |
Pancreatic cancer |
1.217E-05 |
7.094E-04 |
MAPK1, TP53, NFKB1 |
09150 Organismal Systems |
09151 Immune system |
hsa04662 |
B cell receptor signaling pathway |
1.650E-05 |
7.094E-04 |
MAPK1, NFKB1, MALT1 |
09160 Human Diseases |
09161 Cancers |
hsa05220 |
Chronic myeloid leukemia |
1.650E-05 |
7.094E-04 |
MAPK1, TP53, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04010 |
MAPK signaling pathway |
2.337E-05 |
7.536E-04 |
MAPK1, MAPT, TP53, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05215 |
Prostate cancer |
2.993E-05 |
7.721E-04 |
MAPK1, TP53, NFKB1 |
09150 Organismal Systems |
09151 Immune system |
hsa04660 |
T cell receptor signaling pathway |
4.769E-05 |
1.025E-03 |
MAPK1, NFKB1, MALT1 |
09150 Organismal Systems |
09156 Nervous system |
hsa04722 |
Neurotrophin signaling pathway |
7.306E-05 |
1.178E-03 |
MAPK1, TP53, NFKB1 |
09140 Cellular Processes |
09143 Cell growth and death |
hsa04210 |
Apoptosis |
1.155E-04 |
1.490E-03 |
MAPK1, TP53, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04071 |
Sphingolipid signaling pathway |
7.306E-05 |
1.178E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05160 |
Hepatitis C |
9.919E-05 |
1.422E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05161 |
Hepatitis B |
1.308E-04 |
1.534E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05203 |
Viral carcinogenesis |
3.554E-04 |
2.787E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05152 |
Tuberculosis |
2.347E-04 |
2.163E-03 |
MAPK1, NFKB1, MALT1 |
09160 Human Diseases |
09161 Cancers |
hsa05223 |
Non-small cell lung cancer |
6.858E-04 |
4.364E-03 |
MAPK1, TP53 |
09100 Metabolism |
09105 Amino acid metabolism |
hsa00380 |
Tryptophan metabolism |
3.496E-04 |
2.787E-03 |
CYP1A2, IDO1 |
09160 Human Diseases |
09161 Cancers |
hsa05216 |
Thyroid cancer |
1.828E-04 |
1.813E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05213 |
Endometrial cancer |
5.914E-04 |
4.238E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05221 |
Acute myeloid leukemia |
7.104E-04 |
4.364E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05214 |
Glioma |
9.229E-04 |
4.961E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05206 |
MicroRNAs in cancer |
1.045E-03 |
4.993E-03 |
MAPK1, TP53, NFKB1 |
09100 Metabolism |
09103 Lipid metabolism |
hsa00591 |
Linoleic acid metabolism |
1.828E-04 |
1.813E-03 |
CYP1A2, CYP2C19 |
09160 Human Diseases |
09161 Cancers |
hsa05219 |
Bladder cancer |
3.673E-04 |
2.787E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05210 |
Colorectal cancer |
8.400E-04 |
4.926E-03 |
MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04151 |
PI3K-Akt signaling pathway |
1.555E-03 |
5.927E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05230 |
Central carbon metabolism in cancer |
9.802E-04 |
4.993E-03 |
MAPK1, TP53 |
09150 Organismal Systems |
09151 Immune system |
hsa04621 |
NOD-like receptor signaling pathway |
7.104E-04 |
4.364E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05218 |
Melanoma |
1.100E-03 |
4.998E-03 |
MAPK1, TP53 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04917 |
Prolactin signaling pathway |
1.131E-03 |
4.998E-03 |
MAPK1, NFKB1 |
09100 Metabolism |
09111 Xenobiotics biodegradation and metabolism |
hsa00982 |
Drug metabolism - cytochrome P450 |
1.039E-03 |
4.993E-03 |
CYP1A2, CYP2C19 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05131 |
Shigellosis |
9.229E-04 |
4.961E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05200 |
Pathways in cancer |
2.401E-03 |
7.461E-03 |
MAPK1, TP53, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05140 |
Leishmaniasis |
1.162E-03 |
4.998E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
2.209E-03 |
7.461E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05222 |
Small cell lung cancer |
1.608E-03 |
5.927E-03 |
TP53, NFKB1 |
09150 Organismal Systems |
09149 Aging |
hsa04211 |
Longevity regulating pathway - mammal |
1.917E-03 |
6.684E-03 |
TP53, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05133 |
Pertussis |
1.226E-03 |
5.103E-03 |
MAPK1, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04066 |
HIF-1 signaling pathway |
2.296E-03 |
7.461E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05204 |
Chemical carcinogenesis |
1.464E-03 |
5.900E-03 |
CYP1A2, CYP2C19 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04064 |
NF-kappa B signaling pathway |
1.877E-03 |
6.684E-03 |
NFKB1, MALT1 |
09150 Organismal Systems |
09151 Immune system |
hsa04620 |
Toll-like receptor signaling pathway |
2.429E-03 |
7.461E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05142 |
Chagas disease (American trypanosomiasis) |
2.340E-03 |
7.461E-03 |
MAPK1, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04668 |
TNF signaling pathway |
2.613E-03 |
7.838E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05132 |
Salmonella infection |
1.608E-03 |
5.927E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09156 Nervous system |
hsa04726 |
Serotonergic synapse |
2.707E-03 |
7.936E-03 |
MAPK1, CYP2C19 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05145 |
Toxoplasmosis |
2.999E-03 |
8.409E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04919 |
Thyroid hormone signaling pathway |
2.999E-03 |
8.409E-03 |
MAPK1, TP53 |
09100 Metabolism |
09110 Biosynthesis of other secondary metabolites |
hsa00232 |
Caffeine metabolism |
3.495E-03 |
9.594E-03 |
CYP1A2 |